TY  - GEN
AU  - Ma,Brigette B Y
AU  - Lui,Vivian W Y
AU  - Hui,Connie W C
AU  - Lau,Cecilia P Y
AU  - Wong,Chi H
AU  - Hui,Edwin P
AU  - Ng,Margaret H L
AU  - Cheng,Suk H
AU  - Tsao,Sai W
AU  - Tsang,Chi-Man
AU  - Cheung,Crystal S F
AU  - Ho,Kakiu
AU  - Chan,Anthony T C
TI  - Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models
SN  - 1872-7980
PY  - 2014///0220
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Carcinoma
KW  - Cell Cycle
KW  - Cell Line, Tumor
KW  - Cell Survival
KW  - Cisplatin
KW  - Enzyme Activation
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Imidazoles
KW  - Inhibitory Concentration 50
KW  - MAP Kinase Signaling System
KW  - Mice
KW  - Mice, Nude
KW  - Nasopharyngeal Carcinoma
KW  - Nasopharyngeal Neoplasms
KW  - genetics
KW  - Neoplasm Transplantation
KW  - Paclitaxel
KW  - Phosphatidylinositol 3-Kinases
KW  - metabolism
KW  - Phosphoinositide-3 Kinase Inhibitors
KW  - Quinolines
KW  - TOR Serine-Threonine Kinases
KW  - antagonists & inhibitors
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.canlet.2013.09.007
ER  -